You may also like
Bayer Pharmaceuticals Corporation Informs Health Care Professionals Of Important Safety Revisions To The Trasylol Label
Bayer Pharmaceuticals Corporation, in collaboration with the FDA, is informing health care professionals of important safety revisions to the U.S. product information for Trasylol(R) (aprotinin injection) following an FDA Advisory Committee meeting earlier this year.
1 min read
Serological Investigation of Patients with a Previous History of Heparin-Induced Thrombocytopenia who are Re-exposed to Heparin
We conclude that among patients with a previous history of HIT who are reexposed to intraoperative (but not postoperative) heparin, the risk of recurrent HIT appears to be low, but is possible if antibodies with strong heparin-independent platelet-activating properties are formed.
1 min read
Emergent Transventricular Cannulation for a Salvage TAVR Procedure (EP Video)
Erin Herrman presents a case report on emergent transventricular cannulation on a TAVR salvage (27:45 minutes).
1 min read
